InvestorsHub Logo
Followers 0
Posts 35
Boards Moderated 0
Alias Born 09/28/2014

Re: None

Friday, 07/24/2015 12:43:51 PM

Friday, July 24, 2015 12:43:51 PM

Post# of 140475
From Sedar :

This prospectus relates to the offering for sale from time to time, during the 25-month period that this prospectus,
including any amendments hereto, remains effective, of the securities listed above in one or more series or
issuances, with a total offering price of such securities, in the aggregate, of up to U.S. $45,000,000 million. The
securities may be offered separately or together, in amounts, at prices and on terms to be determined based on
market conditions at the time of the sale and set forth in an accompanying prospectus supplement.


The common shares (“Common Shares”) of Titan Medical Inc. (“Titan” or the “Company” or “we” or “our” or “us”)
are listed and posted for trading on the Toronto Stock Exchange (the “TSX”) under the symbol “TMD” and on the
international tier of OTCQX market in the United States under the symbol “TITFX”. Unless otherwise specified in
an applicable prospectus supplement, the Company’s warrants, units, preferred shares and debt securities may not be
listed on any securities or stock exchange or on any automated dealer quotation system.
An investment in the
securities offered hereunder involves a high degree of risk. The risk factors identified under the heading
“Risk Factors” and elsewhere in this prospectus should be carefully reviewed and evaluated by prospective
subscribers before purchasing the securities being offered hereunder. See “Risk Factors”